Haosen(688529)2025-04-29 08:23Financial Performance - The company's operating revenue for Q1 2025 was CNY 505,853,626.89, representing a 15.03% increase compared to CNY 439,740,134.87 in the same period last year[4]. - The net profit attributable to shareholders was a loss of CNY 31,556,714.02, a decrease of 502.97% from a profit of CNY 7,831,077.18 in the previous year[4]. - The basic and diluted earnings per share were both CNY -0.19, a decline of 480.00% from CNY 0.05 in the same period last year[4]. - Net profit for Q1 2025 was a loss of CNY 32.64 million, compared to a profit of CNY 6.67 million in Q1 2024[21]. Cash Flow - The net cash flow from operating activities was CNY 215,719,294.29, a significant improvement from a negative cash flow of CNY -285,756,414.23 in the same period last year[4]. - The company reported a significant increase in cash flow from operating activities, with CNY 824.04 million received from sales in Q1 2025, compared to CNY 394.77 million in Q1 2024[23]. - Cash inflow from investment activities totaled $113,428,576.96, down from $305,071,084.67 in the prior period[24]. - The net cash flow from financing activities increased to $197,326,593.09, compared to $115,770,724.91 previously[25]. - The total cash and cash equivalents at the end of the period reached $894,353,619.68, up from $476,073,570.73 at the end of the previous period[25]. - The net increase in cash and cash equivalents was $490,097,364.79, contrasting with a decrease of $122,526,518.63 in the prior period[25]. Assets and Liabilities - Total assets increased by 5.59% to CNY 6,850,542,244.14 from CNY 6,487,839,783.15 at the end of the previous year[5]. - Total current assets reached ¥5,412,432,278.01, up from ¥5,047,213,185.59, indicating an increase of 7.2%[15]. - Total liabilities increased to CNY 4.86 billion from CNY 4.47 billion, indicating a rise of approximately 8.7%[17]. - The company’s equity attributable to shareholders decreased to CNY 1.99 billion from CNY 2.02 billion, reflecting a decline of about 1%[17]. Research and Development - Research and development expenses totaled CNY 31,286,742.64, down 22.71% from CNY 40,481,412.97, with R&D expenses accounting for 6.18% of operating revenue, a decrease of 3.03 percentage points[5]. - The company has not disclosed any new product developments or technological advancements during the reporting period[13]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,556[10]. - The top shareholder, Dalian Botong Juyuan Industrial Co., Ltd., holds 12.03% of the shares, totaling 20,234,492 shares[12]. - The company reported no changes in the shareholding structure among the top 10 shareholders, with no shares being lent out through margin trading[12]. Market Conditions - The company experienced intensified competition in the downstream market, leading to extended acceptance periods and increased implementation costs, which negatively impacted gross margins[8]. Future Outlook - The company has not provided any specific future guidance or outlook for the upcoming quarters[13]. - There are no significant mergers or acquisitions reported in the recent financial disclosures[13].